Vaxcyte (PCVX) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Vaxcyte, as the data feed reports them.

Analysts' mean target, 10 analysts
$116.40
96.3% above the price

The 10 analysts reported by the data feed have a mean price target for Vaxcyte of $116.40, 96.3% above the $59.30 price (range $75.00–$163.00). 9.81% of the float was sold short as of Oct 30, 2026. Institutions hold 112.0% of the shares and insiders 0.5%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$116.40+96.3% vs price
Analysts
10
Short interest
9.81%of float, Oct 30, 2026
Short ratio
4.16 days
Institutions
112.0%
Insiders
0.47%
Beta
1.29

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

10 analysts covering Vaxcyte, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $59.30.

Analysts' price targets for Vaxcyte
Mean price target$116.4096.3% above the price (+96.3%)
Median price target$121.00104.1% above the price (+104.1%)
Highest target$163.00174.9% above the price (+174.9%)
Lowest target$75.0026.5% above the price (+26.5%)
Analysts with a target10

Ratings this month · 11 analysts

Strong buy 1(9%)Buy 9(82%)Hold 1(9%)
Analysts' ratings of Vaxcyte this month, by rating
RatingAnalystsShare
Strong buy19%
Buy982%
Hold19%
Sell00%
Strong sell00%

The feed averages these to 1.27 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Vaxcyte

Ownership of Vaxcyte
Held by institutions112.0%488 institutions; percent of shares outstanding
Held by institutions, of the float112.5%
Held by insiders0.47%percent of shares outstanding
Shares outstanding158.3M
Float145.89Mshares available to trade
Insiders' net purchases, six months+12.28K22 purchases (181.37K shares), 16 sales (169.09K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Vaxcyte
Shares short15.36Mas of Oct 30, 2026
Percent of float9.81%shares short ÷ float
Percent of shares outstanding9.76%shares short ÷ shares outstanding
Short ratio (days to cover)4.16shares short ÷ average daily volume

Vaxcyte short interest from FINRA, with its history

Trading figures

Trading figures for Vaxcyte
Beta1.29movement against the market; 1 moves with it
52-week high$90.75
52-week low$42.40
Average volume, 3 months2.17Mshares a day
Average volume, 10 days1.47Mshares a day

Questions and answers

What is the analysts' price target for Vaxcyte (PCVX)?

As reported by the data feed, the mean price target of the 10 analysts covering Vaxcyte is $116.40, 96.3% above the latest price of $59.30. The highest target is $163.00 and the lowest $75.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Vaxcyte stock?

Of the 11 ratings the data feed reports for the current month, 1 are strong buy, 9 buy, 1 hold, 0 sell and 0 strong sell.

How many Vaxcyte shares are sold short?

As reported by the data feed, 15.36M shares were sold short, 9.81% of the float as of Oct 30, 2026. At the average daily volume that is 4.16 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Vaxcyte stock?

As reported by the data feed, institutions hold 112.0% of the shares (488 institutions) and insiders 0.5%. There are 158.3M shares outstanding, of which 145.89M are in the float.

How much does Vaxcyte stock move with the market?

Its beta, as reported by the data feed, is 1.29: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $42.40 and $90.75.

Cite this page

Funkfolio, “Vaxcyte (PCVX) statistics: analyst targets, short interest, ownership”, data as of 17 November 2026. https://funkfolio.com/stock/PCVX/statistics

Underlying data: Yahoo Finance.